The first product of Predica Diagnostics will be the ciRNAseq-based CervicaDx assay and a dedicated algorithm. Predica Diagnostics performs the CervicaDx test on cervical scrapes and analyzes the data with a software algorithm that provides a prediction if a woman is at risk of having or developing cervical cancer. Performing the CervicaDx test does not require that an extra scrape is taken.